EUVIMEDEUVIMED entdecken
Crossref

Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer – Results from a Single Institution Study

Benjamin George, Atallah Baydoun, Samar Bhat, Lauryn Bailey, Theodore Arsenault, Yilun Sun, Yuxia Zhang, Yiran Zheng, Prashant Vempati, Tarun Podder, Tithi Biswas

Clinical Lung Cancer · 2024

DOI: 10.1016/j.cllc.2024.02.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2024. Verfasst von Benjamin George und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Case Western Reserve University, Cleveland, OH. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Neoplasm Staging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Stereotactic body radiation therapy (SBRT) is an effective treatment for medically inoperable early-stage non-small cell lung cancer (NSCLC). The prognostic value of invasive nodal staging (INS) for patients undergoing SRBT has not been studied extensively. Herein, we report the impact of INS in addition to 18F-FDG-PET on treatment outcome for patients with NSCLC undergoing SBRT. MATERIALS AND METHODS: Patients with stage I/ II NSCLC who underwent SBRT were included with IRB approval. Clinical, dosimetric, and radiological data were obtained. Overall survival (OS), regional recurrence free survival (RRFS), local recurrence free survival (LRFS), and distant recurrence free survival (DRFS) were analyzed using Kaplan Meyer method. Univariable analysis (UVA) and multivariable analysis (MVA) were performed to assess the relationship between the variables and the outcomes. RESULTS: A total of 376 patients were included in the analysis. Median follow up was 43 months (IQ 32.6-45.8). Median OS, LRFS, RRFS, DRFS were 40, 32, 32, 33 months, respectively. The 5-year local, regional, and distant failure rates were 13.4%, 23.5% and 25.3%, respectively. The 1-year, 3-year and 5-year OS were 83.8%, 55.6%, and 36.3%, respectively. On MVA, INS was not a predictor of either improved overall or any recurrence free survival endpoints while larger tumor size, age, and adjusted Charleston co-morbidity index (aCCI) were significant for inferior LRFS, RRFS, and DRFS. CONCLUSION: Invasive nodal staging did not improve overall or recurrence free survival among patients with early-stage NSCLC treated with SBRT whereas older age, aCCI, and larger tumor size were significant predictors of LRFS, RRFS, and DRFS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgeryNeoplasm StagingHumansMaleFemaleAgedMiddle AgedAged, 80 and overFollow-Up StudiesRetrospective StudiesPrognosisTreatment OutcomeLymph NodesLymphatic MetastasisFluorodeoxyglucose F18Positron-Emission TomographyAdultNeoplasm Recurrence, LocalEndosonographySurvival Rate

Stichwörter der Autor:innen

18-FDG-PETAdjusted Charleston comorbidity indexEBUSNSCLCSBRT

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • School of Medicine, Case Western Reserve University, Cleveland, OH.
  • University Hospitals, Seidman Cancer Center, Cleveland, OH.
  • University Hospitals, Seidman Cancer Center, Cleveland, OH; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH.
  • School of Medicine, Case Western Reserve University, Cleveland, OH; University Hospitals, Seidman Cancer Center, Cleveland, OH.
  • School of Medicine, Case Western Reserve University, Cleveland, OH; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH.
  • School of Medicine, Case Western Reserve University, Cleveland, OH; University Hospitals, Seidman Cancer Center, Cleveland, OH; MetroHealth, Cleveland, OH. Electronic address: tithipodder@gmail.com.

Zitieren

APA

George, B., Baydoun, A., Bhat, S., Bailey, L., Arsenault, T., Sun, Y., Zhang, Y., Zheng, Y., Vempati, P., Podder, T., & Biswas, T. (2024). Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer – Results from a Single Institution Study. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2024.02.007

Vancouver

George B, Baydoun A, Bhat S, Bailey L, Arsenault T, Sun Y, et al. Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer – Results from a Single Institution Study. Clinical Lung Cancer. 2024. doi:10.1016/j.cllc.2024.02.007

BibTeX
@article{George2024,
  author = {George, Benjamin and Baydoun, Atallah and Bhat, Samar and Bailey, Lauryn and Arsenault, Theodore and Sun, Yilun and Zhang, Yuxia and Zheng, Yiran and Vempati, Prashant and Podder, Tarun and Biswas, Tithi},
  title = {Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer – Results from a Single Institution Study},
  journal = {Clinical Lung Cancer},
  year = {2024},
  doi = {10.1016/j.cllc.2024.02.007}
}
Kostenlos starten →